Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Nature|August 31, 2007
Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdUMark J Kiel, Shenghui He, Rina Ashkenazi, et al.
Diabetes Technology & Therapeutics|May 17, 2019
Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c MeasuresJeremy H Pettus, Jake A Kushner, Virginia Valentine, et al.
Diabetes|December 25, 2003
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout miceJake A Kushner, Fawaz G Haj, Lori D Klaman, et al.
Diabetes|February 11, 2011
Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucoseEitan M Akirav, Maria-Teresa Baquero, Lynn W Opare-Addo, et al.
Endocrinology|December 25, 2009
Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesisLi Liang, Wei Hui Guo, Diego R Esquiliano, et al.
Plos One|September 19, 2018
CLEC16A regulates splenocyte and NK cell function in part through MEK signalingRahul Pandey, Marina Bakay, Heather S Hain, et al.
Diabetes Technology & Therapeutics|July 10, 2020
Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin StudyBruce W Bode, Eda Cengiz, R Paul Wadwa, et al.
Molecular Endocrinology (Baltimore, Md.)|July 17, 2012
Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human isletsSebastian Rieck, Jia Zhang, Zhaoyu Li, et al.
Endocrinology|August 4, 2007
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cellsNicole A Sherry, Wei Chen, Jake A Kushner, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2015
Type I interferons mediate pancreatic toxicities of PERK inhibitionQiujing Yu, Bin Zhao, Jun Gui, et al.
Pageof 7